期刊文献+

一例局部晚期乳腺癌的循证综合治疗讨论

暂未订购
导出
摘要 为了给晚期转移性乳腺癌患者带来更多的临床获益,使其拥有更高生活质量的同时能够获得长期生存的机会,我们就一个乳腺癌患者的检查和治疗等方面进行了讨论。
出处 《海南医学》 CAS 2012年第1期135-137,共3页 Hainan Medical Journal
  • 相关文献

参考文献11

  • 1Robert NJ,Eierrnann W,Pienkowski T,et al.BCIRG 006:Docetax.el and trastuzumab-based regimens improve DFS and OS over AC followed by T in node positive and high risk node negative HER2 positive early breast cancer patients:Quality of life at 36 months follow-up[J].J Clin Oncol,2007,25(18S):19647.
  • 2Joensuu H,Kellokumpu-Lentinen P-L,Bono P,et al.Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer[J].N Engl J Med,2006,354:809-820.
  • 3Martin M,Pienkowski T,Mackey J,et al.Adjuvant docetaxel for node-positive breast cancer[J].N Engl J Med,2005,352(22):2302-2313.
  • 4Dang C,Fomier M,Sugaman S,et al.The safety of dose-dense doxorubicin and cyclophosphamide followed by paditaxel with trastuzumab in HER2/neu overexpressed/amplified breast cancer[J].J Clin Oncol,2008,26:1216-1222.
  • 5Seidman AD.Gemcitabine as single-agent therapy in the management of advanced breast cancer[J].Oncology(Huntingt),2001,15(Suppl 3):11-14.
  • 6Romond EH,Perez EZ,Bryant J,et al.Trastuzumab plus adjuvant chemotherapy for operable HER2 positive breast cancer[J].N Engl J Med,2005,353:1673-1684.
  • 7O' Shaughnessy J,Miles D,Vukelja S,et al.Superior survival with capecitabine plus paclitaxel(GT)vs.paclitaxel(T)as frontline therapy for metastatic breast cance(MBC); First Report of Overall Survival[J].J Clin Oncol,2004,22(14S):510.
  • 8Bull JM,Tormey DC,Li SH,et al.A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy[J].Cancer,1978,41:1649-1657.
  • 9Hillner BE,Lngle JN,Chlebowski RT,et al.American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women the breast cancer[J].J Clin Oncol,2003,21(21):4042-4057.
  • 10Gralow JR,Biermann JS,Farooki A,et al.NCCN Task Force Report:Bone health in cancer care[J].J Natl Compr Canc Netw,2009,7(S3):1-32.

二级参考文献12

  • 1王涛,江泽飞,宋三泰,张少华,申戈,于静新.单药希罗达治疗复发转移性乳腺癌的疗效观察[J].中华肿瘤杂志,2004,26(6):379-381. 被引量:57
  • 2Rivera E,Valero V,Arun B,et al.Phase II study of pegylated liposomal doxorubicin in combination with gemcitabine in patients with metastatic breast cancer.J Clin Oncol,2003,21(17):3249-3254.
  • 3Blackstein M,Vogel CL,Ambinder R,et al.Gemcitabine as first-line therapy in patients with metastatic breast cancer:a phase Ⅱ trial.Oncology,2002,62(1):2-8.
  • 4Seidman AD.Gemcitabine as single-agent therapy in the management of advanced breast cancer.Oncology (Williston Park),2001,15(2 Suppl 3):11-14.
  • 5dRuíz GC,Fuentes de la Pe鼻a H,Meza FA,et al.A phase Ⅱ study of gemcitabine plus cisplatin in metastatic breast cancer (MBC).Proc Am SocClin Oncol,2001,20:60b.
  • 6Malmstr(O)m A,Hansen J,Malmberg L,et al.Gemcitabine and capecitabine in combination for advanced anthracycline and taxane pre-treatedbreast cancer patients:A phase Ⅱ study.Acta Oncol,2010,49(1):35-41.
  • 7Ciruelos EM,Cortés J,Cortés-Funes H,et al.Gemcitabine and capecitabine in previously anthracycline-treated metastatic breast cancer:amulticenter phase Ⅱ study (SOLTI 0301 trial).Ann Oncol,2010,21(7):1442-1447.
  • 8Pérez-Manga G,López-Criado P,Mendez M,et al.Gemcitabine (G) plus capecitabine (C) in previously treated metastatic breast cancer (MBC)patients.Results from a phase Ⅱ GOTI trial.Breast Cancer Res Treat,2004,88(Suppl 1):5063 (Abstract).
  • 9Sikov WM,Theall KP,Seidler R,et al.Gemcitabine and capecitabine in metastatic breast cancer (MBC):Brown University Oncology group (BrUOG) phaseⅡstudy.J Clin Oncol,2005,23:785.
  • 10Ahn J,K im S,Lee Y,et al.Phase Ⅱ study of gemcitabine and capecitabine in patients with metastatic breast cancer pretreated withanthracyclinesandtaxanes.J Clin Oncol,2005,23:895.

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部